Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Medicinal cannabis oil for behavioral symptoms in residential aged care residents with dementia
ACTRN12619000474156Phase 2Recruiting
- Sponsor
- University of Notre Dame Australia
- Start
- Feb 2020
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of nabiximols in Dementia (2 arms), sponsored by University of Notre Dame Australia. Primary endpoint: Neuropsychiatric Inventory Questionnaire-Nursing Homes total score at Day 112. Started Feb 2020; status: recruiting.
02
Drugs
nabiximols
03
Conditions
Dementia
Beyond the preview
Go deeper on ACTRN12619000474156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619000474156.